Welcome to LookChem.com Sign In|Join Free
  • or
L-Phenylalanine, N-(N-L-tyrosyl-D-alanyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

80705-25-5

Post Buying Request

80705-25-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

80705-25-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 80705-25-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,7,0 and 5 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 80705-25:
(7*8)+(6*0)+(5*7)+(4*0)+(3*5)+(2*2)+(1*5)=115
115 % 10 = 5
So 80705-25-5 is a valid CAS Registry Number.

80705-25-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name H-Tyr-D-Ala-Phe-OH

1.2 Other means of identification

Product number -
Other names Tyr-D-Ala-Phe-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:80705-25-5 SDS

80705-25-5Downstream Products

80705-25-5Relevant academic research and scientific papers

Opioid Tripeptides Hybridized with trans-1-Cinnamylpiperazine as Proliferation Inhibitors of Pancreatic Cancer Cells in Two- and Three-Dimensional in vitro Models

Laskowska, Anna K.,Puszko, Anna K.,Sosnowski, Piotr,Ró?ycki, Krzysztof,Kosson, Piotr,Matalińska, Joanna,Durlik, Marek,Misicka, Aleksandra

, p. 1637 - 1644 (2017)

According to the World Health Organization, the mortality rate among patients with pancreatic cancer will increase in the upcoming years. Gemcitabine is the first choice for treatment of pancreatic malignancy, but increasing resistance to this drug is dec

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 80705-25-5